Education
About Us
Working with TipRanks
Follow Us
Khavita Harrycharran Insider Profile
4 Followers
Khavita Harrycharran, Director at Restart Life Sciences, holds 1.81M shares in Restart Life Sciences (Ticker: NMLSF). Most recently, Khavita Harrycharran Bought 1,813,808 shares of Restart Life Sciences on Dec 12, 2025 for an estimated value of $200.24K.
Khavita Harrycharran has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Khavita Harrycharran's holdings
Insider Roles
Director
Roles that Khavita Harrycharran holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Khavita Harrycharran
Khavita Harrycharran's Trading History
List of latest transactions for each holding click on a transaction to see Khavita Harrycharran's performance on stock
You May Also Like
Khavita Harrycharran insider profile FAQ
What is the percentage of profitable transactions made by Khavita Harrycharran?
The percentage of profitable transactions made by Khavita Harrycharran is ―.
What is the average return per transaction made by Khavita Harrycharran?
The average return per transaction made by Khavita Harrycharran is ―.
What stocks does Khavita Harrycharran hold?
Khavita Harrycharran holds: NMLSF stocks.
What was Khavita Harrycharran’s latest transaction?
Khavita Harrycharran latest transaction was an Informative Buy of $200.24K.
What was Khavita Harrycharran's most profitable transaction?
Khavita Harrycharran’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Khavita Harrycharran's role in Restart Life Sciences?
Khavita Harrycharran's role in Restart Life Sciences is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.